CA Linker
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Blood groups and transfusion
- Platelet Disorders and Treatments
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
Papers in
-
- Acute Myeloid Leukemia Research 5
- Chronic Myeloid Leukemia Treatments 3
- Hematopoietic Stem Cell Transplantation 3
- Oncology 6
- Neutropenia and Cancer Infections 3
- Cancer Treatment and Pharmacology 2
- Co-authors
- CA Ries (9 shared papers)LE Damon (5 shared papers)SJ Forman (4 shared papers)M O’Donnell (3 shared papers)HS Rugo (3 shared papers)MP Link (2 shared papers)Curt A. Ries (1 shared paper)Lauren E. Damon (1 shared paper)
- Journals
- Blood (8 papers)Bone Marrow Transplantation (1 paper)Arthritis Care & Research (1 paper)PubMed (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
CA Linker
11 papers receiving 572 citations
Peers
Comparison fields: 5 of 45
- Hematology 373
- Nephrology 133
- Immunology 247
- Genetics 117
- Transplantation 21
Countries citing papers authored by CA Linker
This map shows the geographic impact of CA Linker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CA Linker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CA Linker more than expected).
Fields of papers citing papers by CA Linker
This network shows the impact of papers produced by CA Linker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CA Linker. The network helps show where CA Linker may publish in the future.
Co-authors
The 18 scholars most cited alongside CA Linker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 143 | |
| 2 | 1992 | 141 | |
| 3 | 1992 | 122 | |
| 4 | 1987 | 80 | |
| 5 | 1993 | 57 | |
| 6 | Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia. | 1994 | 15 |
| 7 | 2000 | 12 | |
| 8 | 2008 | 11 | |
| 9 | 1991 | 10 | |
| 10 | 1987 | 4 | |
| 11 | 1993 | 4 |
About CA Linker
CA Linker is a scholar working on Hematology, Oncology, Public Health, Environmental and Occupational Health, Genetics and Immunology, having authored 11 papers that have together received 599 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Neutropenia and Cancer Infections (3 papers), Cancer Treatment and Pharmacology (2 papers), Hemoglobinopathies and Related Disorders (2 papers) and Complement system in diseases (2 papers). The work is most often cited by research in Hematology (373 citations), Nephrology (133 citations), Immunology (247 citations), Genetics (117 citations) and Transplantation (21 citations). CA Linker has collaborated with scholars based in United States and Germany. Frequent co-authors include CA Ries, LE Damon, SJ Forman, M O’Donnell, HS Rugo, MP Link, Curt A. Ries, Lauren E. Damon, H. S. Rugo and Kenneth H. Fye. Their work appears in journals such as Blood, Bone Marrow Transplantation, Arthritis Care & Research and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.